ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

EQ Equillium Inc

1,71
-0,10 (-5,52%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Equillium Inc EQ NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,10 -5,52% 1,71 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,85 1,69 1,85 1,71 1,81
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.4.202414:00BWEquillium Reports Inducement Grant Under Nasdaq Listing Rule..
01.4.202414:00BWEquillium Announces Positive Topline Data from the Type B..
25.3.202421:01BWEquillium Reports on Fourth Quarter and Full Year 2023..
22.3.202413:00BWEquillium to Present at the H.C. Wainwright Autoimmune &..
08.3.202423:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
08.3.202422:01EDGAR2Form 8-K - Current report
23.2.202423:12EDGAR2Form 8-K - Current report
23.2.202423:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22.2.202412:08EDGAR2Form 8-K - Current report
04.1.202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202314:05EDGAR2Form 8-K - Current report
21.12.202314:00BWEquillium Announces Update on Multi-Cytokine Inhibitors..
20.11.202317:23PRNCAEQ Bank Card launches in Québec as Carte Banque EQ
13.11.202315:00BWEquillium Presents Positive Data from Phase 1b EQUALISE..
08.11.202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202322:05EDGAR2Form 8-K - Current report
08.11.202322:01BWEquillium Reports Third Quarter 2023 Financial Results and..
06.11.202314:00BWEquillium Announces Data from Phase 1b EQUALISE Study..
19.10.202314:00BWEquillium Announces Abstracts Accepted for Presentation at..
16.10.202314:05EDGAR2Form 8-K - Current report
16.10.202314:00BWEquillium Announces Preclinical Data from New Orally..
05.10.202323:28EDGAR2Form 8-K - Current report
05.10.202323:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03.10.202314:00BWEquillium to Host Analyst & Investor Day
02.10.202314:00BWEquillium to Present at the JonesTrading 2023 Healthcare..
20.9.202314:00BWEquillium to Present at the Cantor Fitzgerald Global..
30.8.202314:00BWEquillium to Attend Wells Fargo Healthcare Conference &..
09.8.202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202322:06EDGAR2Form 8-K - Current report
09.8.202322:01BWEquillium Reports Second Quarter 2023 Financial Results and..
02.8.202322:00BWEquillium Announces $7.5 Million Share Repurchase Program
01.6.202314:00BWEquillium to Present at the Jefferies Global Healthcare & LD..
15.5.202314:00BWEquillium Announces Poster Presentation at the Annual..
11.5.202322:01BWEquillium Reports First Quarter 2023 Financial Results and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock